Filing Details
- Accession Number:
- 0001209191-17-067133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-22 18:08:25
- Reporting Period:
- 2017-12-20
- Accepted Time:
- 2017-12-22 18:08:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590750 | Miragen Therapeutics Inc. | MGEN | Services-Medical Laboratories (8071) | 471187261 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611048 | E. Thomas Hughes | C/O Miragen Therapeutics, Inc. 6200 Lookout Road Boulder CO 80301 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-12-20 | 12,000 | $8.00 | 2,827 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Includes 765 shares previously reported as holdings of the Reporting Person granted pursuant to a restricted stock award under the Issuer's 2016 Equity Incentive Plan.
Billionaire Hedge Funds
